Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7035)
All Articles published online
|
Publishing Process of This Article
|
Feb 21, 2015 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Inada R, Sekine S, Taniguchi H, Tsuda H, Katai H, Fujiwara T, Kushima R. ARID1A expression in gastric adenocarcinoma: Clinicopathological significance and correlation with DNA mismatch repair status. World J Gastroenterol 2015; 21(7): 2159-2168 [PMID: 25717252 DOI: 10.3748/wjg.v21.i7.2159] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i7/2159.htm |
| Number | Citing Articles |
| 1 |
Marta Jessica Llorca-Cardeñosa, Tania Fleitas, Maider Ibarrola-Villava, María Peña-Chilet, Cristina Mongort, Carolina Martinez-Ciarpaglini, Lara Navarro, Valentina Gambardella, Josefa Castillo, Susana Roselló, Samuel Navarro, Gloria Ribas, Andrés Cervantes. Epigenetic changes in localized gastric cancer: the role of RUNX3 in tumor progression and the immune microenvironment. Oncotarget 2016; 7(39): 63424 doi: 10.18632/oncotarget.11520
|
| 2 |
Valli De Re, Giulia Brisotto, Ombretta Repetto, Mariangela De Zorzi, Laura Caggiari, Stefania Zanussi, Lara Alessandrini, Vincenzo Canzonieri, Gianmaria Miolo, Fabio Puglisi, Claudio Belluco, Agostino Steffan, Renato Cannizzaro. Overview of Epstein–Barr-Virus-Associated Gastric Cancer Correlated with Prognostic Classification and Development of Therapeutic Options. International Journal of Molecular Sciences 2020; 21(24): 9400 doi: 10.3390/ijms21249400
|
| 3 |
Chia-Hung Wu, Chien-Hsun Tseng, Kuo-Hung Huang, Wen-Liang Fang, Ming-Huang Chen, Anna F Li, Chew-Wun Wu. The clinical signiicance of ARID1A mutations in gastric cancer patients. Formosan Journal of Surgery 2020; 53(3): 93 doi: 10.4103/fjs.fjs_66_19
|
| 4 |
Fateme Fooladi Talari, Ali Bozorg, Sirous Zeinali, Mohammadreza Zali, Zhale Mohsenifar, Hamid Asadzadeh Aghdaei, Kaveh Baghaei. Low incidence of microsatellite instability in gastric cancers and its association with the clinicopathological characteristics: a comparative study. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-48157-7
|
| 5 |
Yuejing Wang, Zhuo Chen, Jing Wu, Hong Yan, Yiran Wang, Jie He. The Mutation and Low Expression of ARID1A are Predictive of a Poor
Prognosis and High Immune Infiltration in Triple-negative Breast Cancer. Current Cancer Drug Targets 2024; 24(1): 59 doi: 10.2174/1568009623666230522115229
|
| 6 |
Shinichiro Kawatoko, Kenichi Kohashi, Takehiro Torisu, Taisuke Sasaki, Shinya Umekita, Eiji Oki, Masafumi Nakamura, Takanari Kitazono, Yoshinao Oda. Solid-type poorly differentiated adenocarcinoma of the stomach: A characteristic morphology reveals a distinctive immunoregulatory tumor microenvironment. Pathology - Research and Practice 2022; 238: 154124 doi: 10.1016/j.prp.2022.154124
|
| 7 |
Jing Jing Li, Cheok Soon Lee. The Role of the AT-Rich Interaction Domain 1A Gene (ARID1A) in Human Carcinogenesis. Genes 2023; 15(1): 5 doi: 10.3390/genes15010005
|
| 8 |
Hyo Jeong Kang, In-Seob Lee, Young-Soo Park, Won Jin Ho, DaHye Sohn, Ji-Yong Ahn, Jeong-Hwan Yook, Byung-Sik Kim. Biomarkers of EBV-positive Gastric Cancers: Loss of PTEN Expression is Associated with Poor Prognosis and Nodal Metastasis. Annals of Surgical Oncology 2016; 23(11): 3684 doi: 10.1245/s10434-016-5284-2
|
| 9 |
Yun Gu, Puran Zhang, Jieti Wang, Chao Lin, Hao Liu, He Li, Hongyong He, Ruochen Li, Heng Zhang, Weijuan Zhang. Somatic ARID1A mutation stratifies patients with gastric cancer to PD-1 blockade and adjuvant chemotherapy. Cancer Immunology, Immunotherapy 2023; 72(5): 1199 doi: 10.1007/s00262-022-03326-x
|
| 10 |
Inwoo Hwang, Yunjoo Cho, So Young Kang, Deok Geun Kim, Soomin Ahn, Jeeyun Lee, Kyoung-Mee Kim. Comparative analysis of ARID1A mutations with mRNA levels and protein expression in gastric carcinoma. Pathology - Research and Practice 2024; 255: 155063 doi: 10.1016/j.prp.2023.155063
|
| 11 |
Qingyu Luo, Xiaowei Wu, Zhihua Liu. Remodeling of the ARID1A tumor suppressor. Cancer Letters 2020; 491: 1 doi: 10.1016/j.canlet.2020.07.026
|
| 12 |
Yoshihiro Kishida, Takuma Oishi, Takashi Sugino, Akio Shiomi, Kenichi Urakami, Masatoshi Kusuhara, Ken Yamaguchi, Yuko Kitagawa, Hiroyuki Ono. Associations Between Loss of ARID1A Expression and Clinicopathologic and Genetic Variables in T1 Early Colorectal Cancer. American Journal of Clinical Pathology 2019; 152(4): 463 doi: 10.1093/ajcp/aqz062
|
| 13 |
Basile Tessier-Cloutier, Ellen Cai, David F. Schaeffer. Off-label use of common predictive biomarkers in gastrointestinal malignancies: a critical appraisal. Diagnostic Pathology 2019; 14(1) doi: 10.1186/s13000-019-0843-z
|
| 14 |
Yu-Hsuan Hung, Ming-Chuan Hsu, Li-Tzong Chen, Wen-Chun Hung, Mei-Ren Pan. Alteration of Epigenetic Modifiers in Pancreatic Cancer and Its Clinical Implication. Journal of Clinical Medicine 2019; 8(6): 903 doi: 10.3390/jcm8060903
|
| 15 |
Jun Yong Kim, Cheol Keun Park, Songmi Noh, Jae-Ho Cheong, Sung Hoon Noh, Hyunki Kim. Prognostic Significance of ARID1A Expression Patterns Varies with Molecular Subtype in Advanced Gastric Cancer. Gut and Liver 2023; 17(5): 753 doi: 10.5009/gnl220342
|
| 16 |
Kyung-Ju Kim, Hae Yoen Jung, Mee-Hye Oh, Hyundeuk Cho, Ji-Hye Lee, Hyun Ju Lee, Si-Hyong Jang, Moon Soo Lee. Loss of ARID1A Expression in Gastric Cancer: Correlation with Mismatch Repair Deficiency and Clinicopathologic Features. Journal of Gastric Cancer 2015; 15(3): 201 doi: 10.5230/jgc.2015.15.3.201
|
| 17 |
Xiaoqin Zhu, Fang Chen, Yongfu Shao, Dingli Xu, Junming Guo. Long intergenic non-protein coding RNA 1006 used as a potential novel biomarker of gastric cancer. Cancer Biomarkers 2017; 21(1): 73 doi: 10.3233/CBM-170273
|
| 18 |
Rong-Sheng Qin, Chun-Tao Li, Fei Chen, Shu Luo, Chao Wang, Jie Li, Shan Xu, MingWei Kang, Hao-Wen Hu. AURKA inhibition shows promise as a therapeutic strategy for ARID1A-mutant colorectal cancer. Discover Oncology 2024; 15(1) doi: 10.1007/s12672-024-01433-y
|
| 19 |
Lin Yang, Sheng Wei, Rongxian Zhao, Yingxing Wu, Hong Qiu, Huihua Xiong. Loss of ARID1A expression predicts poor survival prognosis in gastric cancer: a systematic meta-analysis from 14 studies. Scientific Reports 2016; 6(1) doi: 10.1038/srep28919
|
| 20 |
Yi Ping Zhu, Li Li Sheng, Jing Wu, Mo Yang, Xian Feng Cheng, Ning Ni Wu, Xiao Bing Ye, Juan Cai, Lu Wang, Qian Shen, Jian Qiu Wu. Loss of ARID1A expression is associated with poor prognosis in patients with gastric cancer. Human Pathology 2018; 78: 28 doi: 10.1016/j.humpath.2018.04.003
|
| 21 |
Shouying Xu, Chao Tang. The Role of ARID1A in Tumors: Tumor Initiation or Tumor Suppression?. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.745187
|
| 22 |
Simon Schallenberg, Julian Bork, Ahlem Essakly, Hakan Alakus, Reinhard Buettner, Axel M. Hillmer, Christiane Bruns, Wolfgang Schroeder, Thomas Zander, Heike Loeser, Florian Gebauer, Alexander Quaas. Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-019-6425-3
|
| 23 |
Lan Su, Rui Yang, Yanan Sheng, Saif Ullah, Yuheng Zhao, Hu Shunjiayi, Zhuo Zhao, Qingjing Wang. Insights into the oral microbiota in human systemic cancers. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1369834
|
| 24 |
Jiawei Guo, Weiwei Yu, Hui Su, Xiufeng Pang. Genomic landscape of gastric cancer: molecular classification and potential targets. Science China Life Sciences 2017; 60(2): 126 doi: 10.1007/s11427-016-0034-1
|
| 25 |
Lei-Lei Guo, Chun-Hua Song, Peng Wang, Li-Ping Dai, Jian-Ying Zhang, Kai-Juan Wang. Competing endogenous RNA networks and gastric cancer. World Journal of Gastroenterology 2015; 21(41): 11680-11687 doi: 10.3748/wjg.v21.i41.11680
|
| 26 |
Michael G. Drage, Mingkhwan Tippayawong, Agoston T. Agoston, Yifan Zheng, Raphael Bueno, Jason L. Hornick, Robert D. Odze, Amitabh Srivastava. Morphological Features and Prognostic Significance of ARID1A-Deficient Esophageal Adenocarcinomas. Archives of Pathology & Laboratory Medicine 2017; 141(7): 970 doi: 10.5858/arpa.2016-0318-OA
|
| 27 |
Xuemei Zhang, Youzhi Zhang, Qiaoyun Zhang, Mengyao Lu, Yuan Chen, Xiaoyu Zhang, Peng Zhang. Role of AT‐rich interaction domain 1A in gastric cancer immunotherapy: Preclinical and clinical perspectives. Journal of Cellular and Molecular Medicine 2024; 28(5) doi: 10.1111/jcmm.18063
|
| 28 |
Adrian Kwan Ho Loe, Roshane Francis, Jieun Seo, Lutao Du, Yunshan Wang, Ji-Eun Kim, Shaheed W. Hakim, Jung-Eun Kim, Housheng Hansen He, Haiyang Guo, Tae-Hee Kim. Uncovering the dosage-dependent roles of Arid1a in gastric tumorigenesis for combinatorial drug therapy. Journal of Experimental Medicine 2021; 218(6) doi: 10.1084/jem.20200219
|
| 29 |
Chang Xu, Kie Kyon Huang, Jia Hao Law, Joy Shijia Chua, Taotao Sheng, Natasha M Flores, Melissa Pool Pizzi, Atsushi Okabe, Angie Lay Keng Tan, Feng Zhu, Vikrant Kumar, Xiaoyin Lu, Ana Morales Benitez, Benedict Shi Xiang Lian, Haoran Ma, Shamaine Wei Ting Ho, Kalpana Ramnarayanan, Chukwuemeka George Anene-Nzelu, Milad Razavi-Mohseni, Siti Aishah Binte Abdul Ghani, Su Ting Tay, Xuewen Ong, Ming Hui Lee, Yu Amanda Guo, Hassan Ashktorab, Duane Smoot, Shang Li, Anders Jacobsen Skanderup, Michael A Beer, Roger Sik Yin Foo, Joel Shi Hao Wong, Kaushal Sanghvi, Wei Peng Yong, Raghav Sundar, Atsushi Kaneda, Shyam Prabhakar, Pawel Karol Mazur, Jaffer A Ajani, Khay Guan Yeoh, Jimmy Bok-Yan So, Patrick Tan. Comprehensive molecular phenotyping ofARID1A-deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunities. Gut 2023; 72(9): 1651 doi: 10.1136/gutjnl-2022-328332
|
| 30 |
Giuseppe Angelico, Giulio Attanasio, Lorenzo Colarossi, Cristina Colarossi, Matteo Montalbano, Eleonora Aiello, Federica Di Vendra, Marzia Mare, Nicolas Orsi, Lorenzo Memeo. ARID1A Mutations in Gastric Cancer: A Review with Focus on Clinicopathological Features, Molecular Background and Diagnostic Interpretation. Cancers 2024; 16(11): 2062 doi: 10.3390/cancers16112062
|
| 31 |
Jhonatan Rabanal-Sanchez. Helicobacter pylori y la expresión de genes en pacientes con adenocarcinoma gástrico. Revista de la Facultad de Ciencias 2020; 9(2): 56 doi: 10.15446/rev.fac.cienc.v9n2.81923
|
| 32 |
Tetsuya Ito, Okihide Suzuki, Nao Kamae, Jun-ichi Tamaru, Tomio Arai, Tatsuro Yamaguchi, Kiwamu Akagi, Hidetaka Eguchi, Yasushi Okazaki, Erito Mochiki, Hideyuki Ishida. Comprehensive analysis of DNA mismatch repair-deficient gastric cancer in a Japanese hospital-based population. Japanese Journal of Clinical Oncology 2021; 51(6): 886 doi: 10.1093/jjco/hyab026
|
| 33 |
Li Zhang, Cuiping Wang, Shuangni Yu, Congwei Jia, Jie Yan, Zhaohui Lu, Jie Chen. Loss of ARID1A Expression Correlates With Tumor Differentiation and Tumor Progression Stage in Pancreatic Ductal Adenocarcinoma. Technology in Cancer Research & Treatment 2018; 17 doi: 10.1177/1533034618754475
|
| 34 |
Ying Shi, Xiao Li, Jin Zhang. Systematic review on the role of the gut microbiota in tumors and their treatment. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1355387
|
| 35 |
Shengqian Zhu, Jinqin Mao, Yongfu Shao, Fang Chen, Xiaoqin Zhu, Dingli Xu, Xinjun Zhang, Junming Guo. Reduced expression of the long non-coding RNA AI364715 in gastric cancer and its clinical significance. Tumor Biology 2015; 36(10): 8041 doi: 10.1007/s13277-015-3543-7
|
| 36 |
K Polom, L Marano, D Marrelli, R De Luca, G Roviello, V Savelli, P Tan, F Roviello. Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer. Journal of British Surgery 2018; 105(3): 159 doi: 10.1002/bjs.10663
|
| 37 |
Byungho Lim, Jong-Hwan Kim, Mirang Kim, Seon-Young Kim. Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancer. World Journal of Gastroenterology 2016; 22(3): 1190-1201 doi: 10.3748/wjg.v22.i3.1190
|
| 38 |
Mikhail Y. Salnikov, Katelyn M. MacNeil, Joe S. Mymryk. The viral etiology of EBV-associated gastric cancers contributes to their unique pathology, clinical outcomes, treatment responses and immune landscape. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1358511
|
| 39 |
Ruihua Wang, Mei Chen, Xiaojun Ye, Karen Poon. Role and potential clinical utility of ARID1A in gastrointestinal malignancy. Mutation Research/Reviews in Mutation Research 2021; 787: 108360 doi: 10.1016/j.mrrev.2020.108360
|
| 40 |
Young-Bae Kim, In-Hye Ham, Hoon Hur, Dakeun Lee. Various ARID1A expression patterns and their clinical significance in gastric cancers. Human Pathology 2016; 49: 61 doi: 10.1016/j.humpath.2015.10.008
|